Secukinumab decreases serum Krebs von den Lungen 6 (KL‐6) level in patients with psoriasis with elevated serum KL‐6 level
Sign Up to like & getrecommendations! Published in 2018 at "British Journal of Dermatology"
DOI: 10.1111/bjd.16993
Abstract: Several papers reported that tumor necrosis factor (TNF)-α inhibitors such as adalimumab (ADA) induced interstitial pneumonia (IP) in patients with rheumatoid arthritis1-3 . We here retrospectively investigated the changes in serum KL-6 levels, which should… read more here.
Keywords: secukinumab decreases; serum krebs; level; decreases serum ... See more keywords